Viewing Study NCT01729260


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 4:09 AM
Study NCT ID: NCT01729260
Status: COMPLETED
Last Update Posted: 2021-05-07
First Post: 2012-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module